MAPT and Alzheimer disease: Immunohistochemical and THK-523 (Figure 2d) fluorescence studies of AD brain sections by Fodero-Tavoletti et al. showed selective binding to argyrophilic tau filaments (PHF-tau) in the hippocampus and frontal regions, but little binding for non-AD tauopathies [106].